Articles with public access mandates - Kenneth AldapeLearn more
Not available anywhere: 11
Review
RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).
MR Gilbert, M Wang, KD Aldape, R Stupp, M Hegi, KA Jaeckle, ...
Journal of Clinical Oncology 29 (15_suppl), 2006-2006, 2011
Mandates: US National Institutes of Health
Review
The genomic landscape of schwannoma
S Agnihotri, S Jalali, MR Wilson, A Danesh, M Li, G Klironomos, ...
Nature genetics 48 (11), 1339-1348, 2016
Mandates: Canadian Institutes of Health Research
Review
Interlaboratory comparison of IDH mutation detection
MJ Van Den Bent, C Hartmann, M Preusser, T Ströbel, HJ Dubbink, ...
Journal of neuro-oncology 112, 173-178, 2013
Mandates: US National Institutes of Health
Review
Beyond grade: molecular pathology of malignant gliomas
EP Sulman, M Guerrero, K Aldape
Seminars in radiation oncology 19 (3), 142-149, 2009
Mandates: US National Institutes of Health
Review
The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline
DP Cahill, AE Sloan, BV Nahed, KD Aldape, DN Louis, TC Ryken, ...
Journal of neuro-oncology 125, 531-549, 2015
Mandates: US National Institutes of Health
Review
Anti-glioma efficacy and mechanism of action of tripolinolate A from Tripolium pannonicum
W Chai, L Chen, XY Lian, Z Zhang
Planta Medica 84 (11), 786-794, 2018
Mandates: National Natural Science Foundation of China
Review
RBTT-11. NRG Oncology NRG-BN006: A Phase II/III randomized, open-label study of Toca 511 and Toca FC with standard of care compared to standard of care in patients with newly …
M Ahluwalia, S Pugh, B Ellingson, R Kotecha, T Cloughesy, ...
Neuro-oncology 21 (Supplement_6), vi220-vi221, 2019
Mandates: US National Institutes of Health
Review
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma
KC Schreck, RE Strowd, LB Nabors, BM Ellingson, M Chang, SK Tan, ...
Clinical Cancer Research 30 (10), 2048-2056, 2024
Mandates: Wellcome Trust
Review
Mutations of FH and IDH may induce gliomagenesis by similar mechanisms
A Raghunathan, CM Ida, EM Westbroek, S Gupta, RB Jenkins, C Giannini, ...
Journal of Neuropathology & Experimental Neurology 82 (1), 99-100, 2023
Mandates: US National Institutes of Health
Review
Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas
J Wang, J Ma
Journal of Neurological Surgery Part A: Central European Neurosurgery 80 (04 …, 2019
Mandates: National Natural Science Foundation of China
Review
Chromosome 7 gain compensates for chromosome 10 loss in glioma
NU Nair, AA Schaffer, EM Gertz, K Cheng, J Zerbib, AD Sahu, G Leor, ...
Cancer Research, 2024
Mandates: European Commission
Available somewhere: 311
Review
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue source sites: Duke University ...
Nature 455 (7216), 1061-1068, 2008
Mandates: US National Institutes of Health
Review
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
Mandates: US National Institutes of Health
Review
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma
H Noushmehr, DJ Weisenberger, K Diefes, HS Phillips, K Pujara, ...
Cancer cell 17 (5), 510-522, 2010
Mandates: US National Institutes of Health
Review
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
Mandates: US National Institutes of Health
Review
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
Mandates: US National Institutes of Health, Helmholtz Association, Cancer Research UK …
Review
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
Mandates: US National Institutes of Health
Review
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma
D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ...
Cancer cell 22 (4), 425-437, 2012
Mandates: Canadian Institutes of Health Research, Genome Canada
Review
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Publication and funding information is determined automatically by a computer program